<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00777842</url>
  </required_header>
  <id_info>
    <org_study_id>08-010</org_study_id>
    <secondary_id>100021, CSCT</secondary_id>
    <nct_id>NCT00777842</nct_id>
  </id_info>
  <brief_title>Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery</brief_title>
  <official_title>Silencing the c-Myc Gene Using Third Generation Antisense Restenosis Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook Group Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook Group Incorporated</source>
  <brief_summary>
    <textblock>
      The GTX™ Drug Eluting Coronary Stent System is intended for the treatment of patients with a
      lesion in the coronary artery.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    In this feasibility study device did not perform as well as expected.
  </why_stopped>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vessel Lumen Patency</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GTX™ Drug Eluting Coronary Stent System</intervention_name>
    <description>Drug eluting stent</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Patient has discrete de novo lesion of a coronary artery with symptomatic ischemic
             heart disease

          -  Planned treatment of one lesion with a single stent

          -  Denovo type A, B1 lesions with a Reference diameter between 3.0 and 3.5mm and a lesion
             length between 5 and 16mm

        Key Exclusion Criteria:

          -  Diabetic (HbA1C &gt;6.0)

          -  Platelet count &lt; 100000 cells/mm3 or &gt; 700000 cells/mm3; WBC &lt; 3000 cells/mm3; or a
             hemoglobin &lt; 10 g/dl

          -  Renal dysfunction with creatinine &gt; 2.0 mg/dl

          -  Patient has a known pre-dilatation ejection fraction (EF) less than forty five (&lt;45%)

          -  Myocardial infarction (MI) less than 3 months prior to intervention

          -  Patient has type B2, C lesion

          -  Reference artery diameter &lt;3.0 or &gt;3.6 mm

          -  Target lesion length &lt; 5mm and &gt;16 mm

          -  Other stenosis &gt;50% in target vessel

          -  Known hypersensitivity or contraindication to aspirin, clopidogrel, ticlopidine, or
             cobalt chromium, or a sensitivity to contrast agent that, in the opinion of the
             investigator, cannot be adequately premedicated.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2008</study_first_submitted>
  <study_first_submitted_qc>October 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2008</study_first_posted>
  <last_update_submitted>December 29, 2015</last_update_submitted>
  <last_update_submitted_qc>December 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

